Precigen (PGEN) Expected to Announce Earnings on Wednesday

Precigen (NASDAQ:PGEN) is expected to release its earnings data before the market opens on Wednesday, March 19th. Analysts expect Precigen to post earnings of ($0.06) per share and revenue of $1.30 million for the quarter.

Precigen Price Performance

Shares of PGEN opened at $1.80 on Monday. The firm has a market capitalization of $527.16 million, a PE ratio of -3.27 and a beta of 1.57. The company’s 50-day moving average is $1.55 and its 200-day moving average is $1.13. Precigen has a fifty-two week low of $0.65 and a fifty-two week high of $2.17.

Analyst Ratings Changes

A number of research firms have recently weighed in on PGEN. HC Wainwright restated a “buy” rating and issued a $6.00 price target (up from $4.00) on shares of Precigen in a research note on Thursday, January 23rd. JMP Securities restated a “market outperform” rating and issued a $5.00 price target on shares of Precigen in a research report on Tuesday, January 14th. Two equities research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $7.00.

About Precigen

Precigen, Inc operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar.